Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
Public ClinicalTrials.gov record NCT01185301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel-Arm, Multicenter Study to Determine the Dose Response of Methotrexate (MTX) in Combination Therapy With Adalimumab in Subjects With Early Rheumatoid Arthritis (CONCERTO)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effects of different doses of methotrexate (MTX) when taken with adalimumab in subjects with early rheumatoid arthritis (RA).
Study identification
- NCT ID
- NCT01185301
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 395 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2010 (Type not available)
- Primary completion
- Sep 2012 (Actual)
- Completion
- Sep 2012 (Actual)
- Last update posted
- Nov 15, 2013
2010 – 2012
United States locations
- U.S. sites
- 30
- U.S. states
- 20
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 38973 | Huntsville | Alabama | 35801 | — |
| Site Reference ID/Investigator# 41962 | Mesa | Arizona | 85202 | — |
| Site Reference ID/Investigator# 39260 | Phoenix | Arizona | 85031 | — |
| Site Reference ID/Investigator# 45323 | Little Rock | Arkansas | 72205 | — |
| Site Reference ID/Investigator# 38912 | Hemet | California | 92543 | — |
| Site Reference ID/Investigator# 39673 | Victorville | California | 92395 | — |
| Site Reference ID/Investigator# 38909 | Jacksonville | Florida | 32209 | — |
| Site Reference ID/Investigator# 40422 | Miami | Florida | 33169 | — |
| Site Reference ID/Investigator# 38910 | Sarasota | Florida | 34239 | — |
| Site Reference ID/Investigator# 44284 | Atlanta | Georgia | 30312 | — |
| Site Reference ID/Investigator# 38907 | Gainesville | Georgia | 30501 | — |
| Site Reference ID/Investigator# 38972 | Lawrenceville | Georgia | 30045 | — |
| Site Reference ID/Investigator# 39670 | Rock Island | Illinois | 61201 | — |
| Site Reference ID/Investigator# 42282 | Springfield | Illinois | 62704 | — |
| Site Reference ID/Investigator# 38911 | Wichita | Kansas | 67203 | — |
| Site Reference ID/Investigator# 39672 | Covington | Louisiana | 70433 | — |
| Site Reference ID/Investigator# 42204 | Omaha | Nebraska | 68114 | — |
| Site Reference ID/Investigator# 40651 | Clifton | New Jersey | 07012 | — |
| Site Reference ID/Investigator# 41422 | Freehold | New Jersey | 07728 | — |
| Site Reference ID/Investigator# 41424 | The Bronx | New York | 10467 | — |
| Site Reference ID/Investigator# 40463 | Greenville | North Carolina | 27834 | — |
| Site Reference ID/Investigator# 42202 | Columbus | Ohio | 43213 | — |
| Site Reference ID/Investigator# 44282 | Norman | Oklahoma | 73069 | — |
| Site Reference ID/Investigator# 41423 | Duncansville | Pennsylvania | 16635 | — |
| Site Reference ID/Investigator# 38971 | Charleston | South Carolina | 29406 | — |
| Site Reference ID/Investigator# 39666 | Jackson | Tennessee | 38305 | — |
| Site Reference ID/Investigator# 39643 | Dallas | Texas | 75231 | — |
| Site Reference ID/Investigator# 45325 | Dallas | Texas | 75246 | — |
| Site Reference ID/Investigator# 52042 | Houston | Texas | 77074 | — |
| Site Reference ID/Investigator# 40602 | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01185301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01185301 live on ClinicalTrials.gov.